4.2 Article

Rho-associated kinase1 promotes laryngeal squamous cell carcinoma tumorigenesis and progression via the FAK signaling pathway

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

FAK in Cancer: From Mechanisms to Therapeutic Strategies

Hsiang-Hao Chuang et al.

Summary: In this review, the authors summarize the mechanisms of FAK-mediated signaling networks during tumor development and the recent progress of FAK-targeted small-molecule compounds for anticancer activity from preclinical and clinical evidence.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Long noncoding RNA LINC00941 promotes pancreatic cancer progression by competitively binding miR-335-5p to regulate ROCK1-mediated LIMK1/Cofilin-1 signaling

Jie Wang et al.

Summary: The study found that LINC00941 acts as an oncogene in the progression of pancreatic cancer, functioning as a ceRNA for miR-335-5p. High expression of LINC00941 was associated with tumor size, lymph node metastasis, and poor prognosis, and its silencing significantly inhibited cell growth and metastasis in PC.

CELL DEATH & DISEASE (2021)

Article Oncology

DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia

Upendarrao Golla et al.

Summary: The ROCK inhibitor DJ4 shows therapeutic efficacy in acute myeloid leukemia, enhancing survival rates and demonstrating cytotoxic effects on AML cells, while sparing normal hematopoietic cells.

CANCERS (2021)

Article Multidisciplinary Sciences

Activation of TMEM16A Ca2+-activated Cl- channels by ROCK1/moesin promotes breast cancer metastasis

Shuya Luo et al.

Summary: Activation of TMEM16A promoted breast cancer cell migration and invasion in vitro as well as breast cancer metastasis in mice. Patients with higher TMEM16A levels showed greater lymph node metastasis and shorter survival.

JOURNAL OF ADVANCED RESEARCH (2021)

Review Oncology

Targeting FAK in anticancer combination therapies

John C. Dawson et al.

Summary: Focal adhesion kinase (FAK) is commonly overexpressed in cancer and involved in various oncogenic processes and resistance mechanisms, making FAK inhibitors most effective as combination therapies in selected patient populations.

NATURE REVIEWS CANCER (2021)

Article Endocrinology & Metabolism

CRF1 Receptor Signaling via the ERK1/2-MAP and Akt Kinase Cascades: Roles of Src, EGF Receptor, and PI3-Kinase Mechanisms

G. Karina Parra-Mercado et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Article Biochemistry & Molecular Biology

Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling

Serena Stadler et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Article Multidisciplinary Sciences

Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer

Clifford J. Whatcott et al.

PLOS ONE (2017)

Review Pharmacology & Pharmacy

WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer

Else Driehuis et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Correction Cell Biology

Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3 (vol 14, 32, 2016)

Nishant P. Visavadiya et al.

CELL COMMUNICATION AND SIGNALING (2017)

Article Oncology

Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment

Marina Roy-Luzarraga et al.

CLINICAL CANCER RESEARCH (2016)

Article Biochemistry & Molecular Biology

Targeted Disruption of ROCK1 Causes Insulin Resistance in Vivo

Dae Ho Lee et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Identification of ROCK1 as an Upstream Activator of the JIP-3 to JNK Signaling Axis in Response to UVB Damage

Pat P. Ongusaha et al.

SCIENCE SIGNALING (2008)

Article Cell Biology

Role of Rho-kinase in regulation of insulin action and glucose homeostasis

N Furukawa et al.

CELL METABOLISM (2005)